Research progress on machine algorithm prediction of liver cancer prognosis after intervention therapy DOI
Feng Guo, Hao Hu, Hao Peng

и другие.

American Journal of Cancer Research, Год журнала: 2024, Номер 14(9), С. 4580 - 4596

Опубликована: Янв. 1, 2024

The treatment for liver cancer has transitioned from traditional surgical resection to interventional therapies, which have become increasingly popular among patients due their minimally invasive nature and significant local efficacy. However, with advancements in technologies, accurately assessing patient response predicting long-term survival a crucial research topic. Over the past decade, machine algorithms made remarkable progress medical field, particularly hepatology prognosis studies of hepatocellular carcinoma (HCC). Machine algorithms, including deep learning learning, can identify prognostic patterns trends by analyzing vast amounts clinical data. Despite advancements, several issues remain unresolved prediction using algorithms. Key challenges main controversies include effectively integrating multi-source data improve accuracy, addressing privacy ethical concerns, enhancing transparency interpretability algorithm decision-making processes. This paper aims systematically review analyze current applications potential undergoing therapy cancer, providing theoretical empirical support future practice.

Язык: Английский

Use of Artificial Intelligence for Liver Diseases: A Survey from the EASL Congress 2024 DOI Creative Commons
Laura Žigutytė, Thomas Sorz, Jan Clusmann

и другие.

JHEP Reports, Год журнала: 2024, Номер 6(12), С. 101209 - 101209

Опубликована: Сен. 6, 2024

Язык: Английский

Процитировано

8

Mapping the landscape of biliary tract cancer in Europe: challenges and controversies DOI Creative Commons
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp

и другие.

The Lancet Regional Health - Europe, Год журнала: 2025, Номер 50, С. 101171 - 101171

Опубликована: Фев. 19, 2025

Biliary tract cancer (BTC) is becoming more common worldwide, with geographic differences in incidence and risk factors. In Europe, BTC may be associated primary sclerosing cholangitis, lithiasis, liver cirrhosis, but frequently observed as a sporadic disease. increasingly affects patients under 60 years, resulting significant social economic burden. Early diagnosis remains challenging due to vague symptoms 50% of BTC, lack specific biomarkers, late presentation poor prognosis. The identification at increased reliable biomarkers require collaborative efforts make faster progress. This Series paper highlights the disparities access diagnostic tools multidisciplinary care particularly economically disadvantaged regions, while identifying priority areas for improvement. Addressing these inequities requires harmonised guidelines, accelerated pathways curative treatments, improved awareness among healthcare professionals public. Multidisciplinary teams (MDTs) are crucial improving patient outcomes, yet inconsistencies exist their implementation not only between different countries, also centres within country. Collaboration standardisation treatment protocols across Europe essential effectively address management BTC.

Язык: Английский

Процитировано

1

Predicting Immunotherapy Response in Unresectable Hepatocellular Carcinoma: A Comparative Study of Large Language Models and Human Experts DOI

Jun Xu,

Junjie Wang, Junjun Li

и другие.

Journal of Medical Systems, Год журнала: 2025, Номер 49(1)

Опубликована: Май 15, 2025

Язык: Английский

Процитировано

1

Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges DOI Creative Commons
Antonio Cigliano, Weiting Liao, Giovanni Deiana

и другие.

Biomedicines, Год журнала: 2024, Номер 12(7), С. 1624 - 1624

Опубликована: Июль 22, 2024

Hepatocellular carcinoma (HCC), the predominant primary liver tumor, remains one of most lethal cancers worldwide, despite advances in therapy recent years. In addition to traditional chemically and dietary-induced HCC models, a broad spectrum novel preclinical tools have been generated following advent transgenic, transposon, organoid, silico technologies overcome this gloomy scenario. These models become rapidly robust instruments unravel molecular pathogenesis cancer establish new therapeutic approaches against deadly disease. The present review article aims summarize discuss commonly used for HCC, evaluating their strengths weaknesses.

Язык: Английский

Процитировано

5

Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data DOI Creative Commons
Qianqian Guo, Xiaorong Zhu, Narasimha M. Beeraka

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Ноя. 15, 2024

Incidence of liver cancer as one the most common cancers worldwide and become significant contributor for mortality among patients. The disease burden, risk factors, trends in incidence globally was described subsequently estimated projections or by 2040. Data regarding age-standardized rates obtained from multiple databases, including GLOBOCAN 2020, CI5 volumes I–XI, WHO database, Global Burden Disease (GBD)-2019. Concentrating on variations, this thorough analysis offers insights into patterns based gender age. Our findings encompass indicators, (ASRs), average annual percentage change (AAPC), future extending up to year Liver holds sixth position terms frequently diagnosed stands leading cause cancer-related deaths accounting 905,677 new cases 782,000 fatalities. Additionally, contributed 12,528,421 disability-adjusted life years (DALYs), with an DALYs rate 161.92 2019 worldwide. age-specific exhibited variations across different regions, showing a fivefold difference males females. A increase observed North Europe Asia, while African countries reported higher burden (ASR, 10 per 100,000) compared developed countries. Since last few years, have increased attained Annual Average Percentage Change (AAPC) 7.7 (95% CI 3.9–11.6) men highest AAPC 12.2 9.5–15.0) women. In 2019, Western emerged high-risk region related smoking alcohol consumption, high-income America carried high associated body-mass index. projected trend indicates surge incident cases, expected rise around 905,347 1,392,474 This study evidence pertinent cancer, particularly both young older adults, encompassing females, well those who are HIV-infected HBsAg positive. population poses public health concern that warrants attention healthcare professionals prioritize promotion awareness development effective prevention strategies, many developing

Язык: Английский

Процитировано

4

Evolving and Novel Applications of Artificial Intelligence in Abdominal Imaging DOI Creative Commons
Margaret L. Loper, Mina S. Makary

Tomography, Год журнала: 2024, Номер 10(11), С. 1814 - 1831

Опубликована: Ноя. 18, 2024

Advancements in artificial intelligence (AI) have significantly transformed the field of abdominal radiology, leading to an improvement diagnostic and disease management capabilities. This narrative review seeks evaluate current standing AI imaging, with a focus on recent literature contributions. work explores diagnosis characterization hepatobiliary, pancreatic, gastric, colonic, other pathologies. In addition, role has been observed help differentiate renal, adrenal, splenic disorders. Furthermore, workflow optimization strategies quantitative imaging techniques used for measurement tissue properties, including radiomics deep learning, are highlighted. An assessment how these advancements enable more precise diagnosis, tumor description, body composition evaluation is presented, which ultimately advances clinical effectiveness productivity radiology. Despite technical, ethical, legal challenges persist, challenges, as well opportunities future development,

Язык: Английский

Процитировано

3

Advancements in Artificial Intelligence-Enhanced Imaging Diagnostics for the Management of Liver Disease—Applications and Challenges in Personalized Care DOI Creative Commons
Naoshi Nishida

Bioengineering, Год журнала: 2024, Номер 11(12), С. 1243 - 1243

Опубликована: Дек. 9, 2024

Liver disease can significantly impact life expectancy, making early diagnosis and therapeutic intervention critical challenges in medical care. Imaging diagnostics play a crucial role diagnosing managing liver diseases. Recently, the application of artificial intelligence (AI) imaging analysis has become indispensable healthcare. AI, trained on vast datasets images, sometimes demonstrated diagnostic accuracy that surpasses human experts. AI-assisted are expected to contribute standardization quality. Furthermore, AI potential identify image features imperceptible humans, thereby playing an essential clinical decision-making. This capability enables physicians make more accurate diagnoses develop effective treatment strategies, ultimately improving patient outcomes. Additionally, is anticipated powerful tool personalized medicine. By integrating individual data with information, propose optimal plans for treatment, it component provision most appropriate care each patient. Current reports highlight advantages As technology continues evolve, advance treatments overall improvements healthcare

Язык: Английский

Процитировано

3

Artificial intelligence in surgical medicine: a brief review DOI Open Access
Guo Chen,

Yutao He,

Zhitian Shi

и другие.

Annals of Medicine and Surgery, Год журнала: 2025, Номер 87(4), С. 2180 - 2186

Опубликована: Фев. 27, 2025

The application of artificial intelligence (AI) technology in the medical field, particularly surgical operations, has evolved from science fiction to a crucial tool. With continuous advancements computational power and algorithmic technology, AI is reshaping medicine landscape. From preoperative diagnosis planning intraoperative real-time navigation assistance postoperative rehabilitation follow-up management, significantly enhanced precision safety procedures. This paper systematically reviews development current applications surgery, focusing on specific case studies procedures, diagnostic assistance, navigation, highlighting its significant contributions improving safety. Despite obvious advantages success, reducing complications, accelerating patient recovery, use surgery still faces numerous challenges, including cost-effectiveness, dependency, data privacy security, clinical integration, physician training. review summarizes medicine, highlights benefits limitations, discusses challenges future directions integrating into practice.

Язык: Английский

Процитировано

0

Is it necessary to distinguish between combined hepatocellular carcinoma-cholangiocarcinoma with less than 10% of cholangiocarcinoma components versus hepatocellular carcinoma? DOI
Valérie Paradis

Hepatology International, Год журнала: 2025, Номер unknown

Опубликована: Апрель 30, 2025

Язык: Английский

Процитировано

0

New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma DOI Creative Commons
Chengbo Li,

Bingjiu Lu,

Baocheng Deng

и другие.

Biomedicines, Год журнала: 2025, Номер 13(5), С. 1244 - 1244

Опубликована: Май 20, 2025

Hepatocellular carcinoma remains one of the leading contributors to global cancer mortality, frequently stemming from chronic liver conditions, such as viral hepatitis, non-alcoholic fatty disease, and alcohol-induced cirrhosis. While antiviral treatments have made significant strides, rising prevalence hepatocellular linked non-infectious causes underscores pressing demand for more effective diagnostic tools therapeutic interventions. Advances in imaging liquid biopsy technologies facilitated early detection diagnosis, treatment strategies are diversifying include immune checkpoint inhibitors, tyrosine kinase interventional therapies. Translational therapies advanced improved surgical opportunities patient survival. Artificial intelligence has played a transformative role diagnosis carcinoma, terms image analysis, histopathologic classification, drug development, targeted therapy. The future lies precision oncology collaboration multidisciplinary teams, well detection. ultimate goal is keep patients alive longer reduce burden this complex malignancy.

Язык: Английский

Процитировано

0